PCRX Share Price

Open 48.35 Change Price %
High 48.72 1 Day -1.30 -2.69
Low 47.00 1 Week -3.45 -6.84
Close 47.00 1 Month 1.80 3.98
Volume 555818 1 Year 3.54 8.15
52 Week High 58.95
52 Week Low 29.95
PCRX Important Levels
Resistance 2 48.59
Resistance 1 47.94
Pivot 47.57
Support 1 46.06
Support 2 45.41
NASDAQ USA Most Active Stocks
GOOG 941.86 0.84%
GOOG 941.86 0.84%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
DCTH 0.03 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
More..
NASDAQ USA Top Gainers Stocks
MNGA 1.92 966.67%
HAUP 0.17 88.89%
NUTR 42.15 50.54%
LOCM 0.09 50.00%
OPXAW 0.03 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
COOL 16.78 24.85%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX)

PCRX Technical Analysis 1.5
As on 22nd May 2017 PCRX Share Price closed @ 47.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 39.86 & Sell for SHORT-TERM with Stoploss of 47.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
PCRX Target for May
1st Target up-side 51.55
2nd Target up-side 53.65
3rd Target up-side 55.75
1st Target down-side 45.55
2nd Target down-side 43.45
3rd Target down-side 41.35
PCRX Other Details
Segment EQ
Market Capital 512069248.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pacira.com
PCRX Address
PCRX
5 Sylvan Way
Suite 100
Parsippany, NJ 07054
United States
Phone: 973-254-3560
PCRX Latest News
Interactive Technical Analysis Chart Pacira Pharmaceuticals, Inc. ( PCRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacira Pharmaceuticals, Inc.
PCRX Business Profile
Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome injection) is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine; and DepoDur (morphine sulfate extended-release liposome injection) is an extended-release, injectable formulation of morphine.